UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 26, 2011
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 000-10030
APPLE INC.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
Registrant s telephone number, including area code: (408) 996-1010
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
924,754,561 shares of common stock issued and outstanding as of April 8, 2011
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in millions, except share amounts which are reflected in thousands and per share amounts)
Three Months Ended
Six Months Ended
March 26,
2011
March 27,
2010
March 26,
2011
March 27,
2010
Net sales
24,667
13,499
51,408
29,182
Cost of sales
14,449
7,874
30,892
17,146
Gross margin
10,218
5,625
20,516
12,036
Operating expenses:
Research and development
581
426
1,156
824
Selling, general and administrative
1,763
1,220
3,659
2,508
Total operating expenses
2,344
1,646
4,815
3,332
Operating income
7,874
3,979
15,701
8,704
Other income and expense
26
50
162
83
Income before provision for income taxes
7,900
4,029
15,863
8,787
Provision for income taxes
1,913
955
3,872
2,335
Net income
5,987
3,074
11,991
6,452
Earnings per common share:
Basic
6.49
3.39
13.02
7.12
Diluted
6.40
3.33
12.83
7.00
Shares used in computing earnings per share:
Basic
923,196
907,548
921,245
905,545
Diluted
935,944
922,878
934,549
921,331
See accompanying Notes
to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except
share amounts)
March 26,
2011
September 25,
2010
ASSETS:
Current assets:
Cash and cash equivalents
15,978
11,261
Short-term marketable securities
13,256
14,359
Accounts receivable, less allowances of $57 and $55, respectively
5,798
5,510
Inventories
930
1,051
Deferred tax assets
1,683
1,636
Vendor non-trade receivables
5,297
4,414
Other current assets
4,055
3,447
Total current assets
46,997
41,678
Long-term marketable securities
36,533
25,391
Property, plant and equipment, net
6,241
4,768
Goodwill
741
741
Acquired intangible assets, net
507
342
Other assets
3,885
2,263
Total assets
94,904
75,183
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
13,714
12,015
Accrued expenses
7,022
5,723
Deferred revenue
3,591
2,984
Total current liabilities
24,327
20,722
Deferred revenue non-current
1,230
1,139
Other non-current liabilities
7,870
5,531
Total liabilities
33,427
27,392
Commitments and contingencies
Shareholders equity:
Common stock, no par value; 1,800,000,000 shares authorized; 924,674,079 and 915,970,050 shares issued and outstanding,
respectively
12,326
10,668
Retained earnings
49,025
37,169
Accumulated other comprehensive income/(loss)
126
(46
Total shareholders equity
61,477
47,791
Total liabilities and shareholders equity
94,904
75,183
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
Six Months Ended
March 26,
2011
March 27,
2010
Cash and cash equivalents, beginning of the period
11,261
5,263
Operating activities:
Net income
11,991
6,452
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation, amortization and accretion
790
425
Stock-based compensation expense
586
436
Deferred income tax expense
1,563
893
Changes in operating assets and liabilities:
Accounts receivable, net
(288
482
Inventories
121
(183
Vendor non-trade receivables
(883
(47
Other current and non-current assets
(1,886
(619
Accounts payable
1,626
(18
Deferred revenue
698
577
Other current and non-current liabilities
1,674
(287
Cash generated by operating activities
15,992
8,111
Investing activities:
Purchases of marketable securities
(42,260
(25,061
Proceeds from maturities of marketable securities
10,211
13,331
Proceeds from sales of marketable securities
21,705
8,686
Payments made in connection with business acquisitions, net of cash acquired
(325
Payments for acquisition of property, plant and equipment
(1,838
(650
Payments for acquisition of intangible assets
(81
(32
Other
12
10
Cash used in investing activities
(12,251
(4,041
Financing activities:
Proceeds from issuance of common stock
494
534
Excess tax benefits from equity awards
740
413
Taxes paid related to net share settlement of equity awards
(258
(262
Cash generated by financing activities
976
685
Increase in cash and cash equivalents
4,717
4,755
Cash and cash equivalents, end of the period
15,978
10,018
Supplemental cash flow disclosure:
Cash paid for income taxes, net
1,913
2,144
See accompanying Notes
to Condensed Consolidated Financial Statements.
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs, manufactures, and
markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications. The
Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as third-party cellular network carriers, wholesalers, resellers and value-added resellers. In addition, the Company sells a variety of
third-party iPhone, iPad, Macintosh ( Mac ), and iPod compatible products including application software, printers, storage devices, speakers, headphones, and various other accessories and supplies through its online and retail stores. The
Company sells to consumers, small and mid-sized businesses, education, enterprise and government customers.
Basis of Presentation and
Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany
accounts and transactions have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and
assumptions that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated
financial statements and notes thereto have been reclassified to conform to the current period s presentation.
These
condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal year ended September 25, 2010, included in
its Annual Report on Form 10-K (the 2010 Form 10-K ). Unless otherwise stated, references to particular years or quarters refer to the Company s fiscal years ended in September and the associated quarters of those fiscal years.
During the first quarter of 2011, the Company adopted the Financial Accounting Standard Board s ( FASB ) new
accounting standard on consolidation of variable interest entities. This new accounting standard eliminates the mandatory quantitative approach in determining control for evaluating whether variable interest entities need to be
consolidated in favor of a qualitative analysis, and requires an ongoing reassessment of control over such entities. The adoption of this new accounting standard did not impact the Company s condensed consolidated financial
statements.
Earnings Per Common Share
Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per
common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have
been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding options, shares to be purchased under the employee stock purchase plan, and unvested restricted stock units
( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the
Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table summarizes the computation of basic and diluted earnings per common
share for the three- and six-month periods ended March 26, 2011 and March 27, 2010 (in thousands, except net income in millions and per share amounts):
Three Months Ended
Six Months Ended
March 26,
2011
March 27,
2010
March 26,
2011
March 27,
2010
Numerator:
Net income
5,987
3,074
11,991
6,452
Denominator:
Weighted-average shares outstanding
923,196
907,548
921,245
905,545
Effect of dilutive securities
12,748
15,330
13,304
15,786
Weighted-average diluted shares
935,944
922,878
934,549
921,331
Basic earnings per common share
6.49
3.39
13.02
7.12
Diluted earnings per common share
6.40
3.33
12.83
7.00
Potentially dilutive
securities representing approximately 220,000 shares and 1.3 million shares of common stock for the three months ended March 26, 2011 and March 27, 2010, respectively, and 297,000 shares and 772,000 shares of common stock for the six
months ended March 26, 2011 and March 27, 2010, respectively, were excluded from the computation of diluted earnings per common share for these periods because their effect would have been antidilutive.
Fair Value Measurements
Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest
level of input that is available and significant to the fair value measurement:
Level 1 Quoted prices in active
markets for identical assets or liabilities.
Level 2 Observable inputs other than quoted prices in active
markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of
the assets or liabilities.
Level 3 Inputs that are generally unobservable and typically reflect
management s estimate of assumptions that market participants would use in pricing the asset or liability.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables
summarize the Company s available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short-term or long-term
marketable securities as of March 26, 2011 and September 25, 2010 (in millions):
March 26, 2011
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
3,203
3,203
3,203
Level 1:
Money market funds
1,908
1,908
1,908
Level 2:
U.S. Treasury securities
10,379
(18
10,369
1,930
2,046
6,393
U.S. agency securities
10,213
(7
10,212
2,463
2,222
5,527
Non-U.S. government securities
3,638
(2
3,640
1,203
2,437
Certificates of deposit and time deposits
3,628
(2
3,627
868
797
1,962
Commercial paper
6,881
6,881
5,542
1,339
Corporate securities
23,030
68
(31
23,067
51
5,159
17,857
Municipal securities
2,856
10
(6
2,860
13
490
2,357
Subtotal
60,625
97
(66
60,656
10,867
13,256
36,533
Total
65,736
97
(66
65,767
15,978
13,256
36,533
September 25, 2010
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
1,690
1,690
1,690
Level 1:
Money market funds
2,753
2,753
2,753
Level 2:
U.S. Treasury securities
9,872
42
9,914
2,571
2,130
5,213
U.S. agency securities
8,717
10
8,727
1,916
4,339
2,472
Non-U.S. government securities
2,648
13
2,661
10
865
1,786
Certificates of deposit and time deposits
2,735
(1
2,739
374
850
1,515
Commercial paper
3,168
3,168
1,889
1,279
Corporate securities
17,349
102
(9
17,442
58
4,522
12,862
Municipal securities
1,899
19
(1
1,917
374
1,543
Subtotal
46,388
191
(11
46,568
6,818
14,359
25,391
Total
50,831
191
(11
51,011
11,261
14,359
25,391
The net unrealized gains as of March 26, 2011 and September 25, 2010 related primarily to
long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The
Company recognized net realized gains of $41 million and $56 million during the three- and six-month periods ended March 26, 2011, respectively. The Company recognized no significant net realized gains or losses during the three- and six-month
periods ended March 27, 2010. The maturities of the Company s long-term marketable securities generally range from one year to five years.
As of March 26, 2011 and September 25, 2010, gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.
The Company considers the declines in market value of its marketable securities investment portfolio to be temporary in
nature. The Company typically invests in highly-rated securities, and its policy generally limits the amount of credit exposure to any one issuer. The Company s investment policy requires investments to generally be investment grade, primarily
rated single-A or better, with the objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating the investments for other-than-temporary
impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company s intent to sell, or whether it is more
likely than not it will be required to sell, the investment before recovery of the investment s amortized cost basis. During the three- and six-month periods ended March 26, 2011 and March 27, 2010, the Company did not recognize any
significant impairment charges. As of March 26, 2011, the Company does not consider any of its investments to be other-than-temporarily impaired.
Derivative Financial Instruments
The Company uses derivatives to partially
offset its business exposure to foreign currency exchange risk. The Company may enter into foreign currency forward and option contracts to offset some of the foreign exchange risk on expected future cash flows on certain forecasted revenue and cost
of sales, on net investments in certain foreign subsidiaries, and on certain existing assets and liabilities. To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s subsidiaries whose
functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion of forecasted
inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases for three to six months. To help
protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments
due to fluctuations in foreign currency exchange rates. The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain
assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not limited to, materiality, accounting considerations
and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.
The Company s accounting policies for these instruments are based on whether the
instruments are designated as hedge or non-hedge instruments. The Company records all derivatives on the Condensed Consolidated Balance Sheets at fair value. The effective portions of cash flow hedges are recorded in other comprehensive income until
the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net investment
hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item the derivative relates to.
The Company had a net deferred loss associated with cash flow hedges of approximately $91 million and $252 million, net of taxes,
recorded in other comprehensive income as of March 26, 2011 and September 25, 2010, respectively. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same
period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Substantially all of
the Company s hedged transactions as of March 26, 2011 are expected to occur within six months.
Derivative
instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and
losses in other comprehensive income associated with such derivative instruments are reclassified immediately into earnings through other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other
income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three- and
six-month periods ended March 26, 2011 and March 27, 2010.
The Company s unrealized net gains and losses on
net investment hedges, included in the cumulative translation adjustment account of accumulated other comprehensive income ( AOCI ), were not significant as of March 26, 2011 and September 25, 2010, respectively. The ineffective
portions and amounts excluded from the effectiveness test of net investment hedges are recorded in other income and expense.
The Company recognized in earnings a net loss on foreign currency forward and option contracts not designated as hedging instruments of
$84 million and $55 million during the three- and six-month periods ended March 26, 2011, respectively, and a net gain on foreign currency forward and option contracts not designated as hedging instruments of $24 million and a net loss of $10
million during the three- and six-month periods ended March 27, 2010, respectively. These amounts recorded in other income and expense represent the net gain or loss on the derivative contracts and do not include changes in the related
exposures, which generally offset a portion of the gain or loss on the derivative contracts.
The following table summarizes the notional principal amounts of the Company s
outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of March 26, 2011 and September 25, 2010 (in millions):
March 26, 2011
September 25, 2010
Notional
Principal
Credit Risk
Amounts
Notional
Principal
Credit Risk
Amounts
Instruments qualifying as accounting hedges:
Foreign exchange contracts
10,393
27
13,957
62
Instruments other than accounting hedges:
Foreign exchange contracts
8,460
10,727
45
The notional
principal amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and does not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the
Company s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at
each respective date. The Company s gross exposure on these transactions may be further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function
of currency exchange rates. Although the table above reflects the notional principal and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions
that the foreign exchange instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions
during the remaining life of the instruments.
The Company generally enters into master netting arrangements, which reduce
credit risk by permitting net settlement of transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net
fair value of certain financial instruments fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of March 26, 2011, the Company posted cash
collateral related to the derivative instruments under its collateral security arrangements of $64 million and recorded the offsetting balance as other current assets in the Condensed Consolidated Balance Sheet. As of September 25, 2010,
the Company posted cash collateral related to the derivative instruments under its collateral security arrangements of $445 million and recorded the offsetting balance as other current assets in the Condensed Consolidated Balance Sheet. The Company
did not have any derivative instruments with credit-risk related contingent features that would require it to post additional collateral as of March 26, 2011 or September 25, 2010.
The following tables summarize the gross fair value of the Company s derivative instruments as reflected in the Condensed
Consolidated Balance Sheets as of March 26, 2011 and September 25, 2010 (in millions):
March 26, 2011
Fair Value of
Derivatives
Designated
as
Hedge
Instruments
Fair Value of
Derivatives
Not Designated
as
Hedge
Instruments
Total
Fair Value
Derivative assets (a):
Foreign exchange contracts
27
32
Derivative liabilities (b):
Foreign exchange contracts
178
56
234
10
September 25, 2010
Fair Value of
Derivatives
Designated
as
Hedge
Instruments
Fair Value of
Derivatives
Not Designated
as Hedge
Instruments
Total
Fair Value
Derivative assets (a):
Foreign exchange contracts
62
45
107
Derivative liabilities (b):
Foreign exchange contracts
488
118
606
(a)
The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed
Consolidated Balance Sheets.
(b)
The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed
Consolidated Balance Sheets.
The following table summarizes the pre-tax effect of the Company s
derivative instruments designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three- and six-month periods ended March 26, 2011 and March 27, 2010 (in millions):